Home › NDC Lookup › RxCUI directory › RxCUI 2732298

2 ML narsoplimab-wuug 185 MG/ML Injection — RxCUI 2732298

RxNorm drug concept · Semantic clinical drug
RxCUI 2732298 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2732298
Official name2 ML narsoplimab-wuug 185 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnarsoplimab-wuug 370 MG per 2 ML Injection; narsoplimab-wuug 370 MG in 2 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 2 ML narsoplimab-wuug 185 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML narsoplimab-wuug 185 MG/ML Injection RxCUI 2732298

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Narsoplimab 2732291
    • Narsoplimab-wuug 2732292
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Yartemlea 2732300
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Narsoplimab Injection 2732295
    • Narsoplimab-wuug Injection 2732297
    • Narsoplimab Injectable Product 2732294
    • Narsoplimab-wuug Injectable Product 2732296
    • Narsoplimab Injection [Yartemlea] 2732303
    • Narsoplimab-wuug Injection [Yartemlea] 2732304
    • Yartemlea Injectable Product 2732302
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Narsoplimab-wuug 185 MG/ML SCDC · 2732293
  • Narsoplimab Injection SCDF · 2732295
  • Narsoplimab-wuug Injection SCDFP · 2732297
  • Narsoplimab Injectable Product SCDG · 2732294
  • Narsoplimab-wuug Injectable Product SCDGP · 2732296

Brand-Name Concepts

  • 2 ML narsoplimab-wuug 185 MG/ML Injection [Yartemlea] SBD · 2732305
  • Narsoplimab-wuug 185 MG/ML [Yartemlea] SBDC · 2732301
  • Narsoplimab Injection [Yartemlea] SBDF · 2732303
  • Narsoplimab-wuug Injection [Yartemlea] SBDFP · 2732304
  • Yartemlea Injectable Product SBDG · 2732302
  • Yartemlea BN · 2732300

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2732298 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62225-0300-00 1 VIAL in 1 CARTON (62225-300-00) / 2 mL in 1 VIAL YARTEMLEA Omeros Corporation 2026-01-20
Observed labelers: Omeros Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.